These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 23044079
1. The pro-inflammatory action of tumour necrosis factor-α in non-alcoholic steatohepatitis is independent of the NSMAF gene product. Mas E, Danjoux M, Garcia V, Carpentier S, Ségui B, Levade T. Dig Liver Dis; 2013 Feb; 45(2):147-54. PubMed ID: 23044079 [Abstract] [Full Text] [Related]
2. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. Koppe SW, Sahai A, Malladi P, Whitington PF, Green RM. J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239 [Abstract] [Full Text] [Related]
3. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet. Luo XY, Takahara T, Kawai K, Fujino M, Sugiyama T, Tsuneyama K, Tsukada K, Nakae S, Zhong L, Li XK. Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786 [Abstract] [Full Text] [Related]
4. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J, Teoh N, Sedger LM. J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377 [Abstract] [Full Text] [Related]
5. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency. Kirsch R, Clarkson V, Verdonk RC, Marais AD, Shephard EG, Ryffel B, de la M Hall P. J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830 [Abstract] [Full Text] [Related]
6. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF. Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174 [Abstract] [Full Text] [Related]
7. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator. Yu J, Ip E, Dela Peña A, Hou JY, Sesha J, Pera N, Hall P, Kirsch R, Leclercq I, Farrell GC. Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554 [Abstract] [Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC. J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330 [Abstract] [Full Text] [Related]
9. Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice. Nan YM, Han F, Kong LB, Zhao SX, Wang RQ, Wu WJ, Yu J. Scand J Gastroenterol; 2011 Mar; 46(3):358-69. PubMed ID: 20969493 [Abstract] [Full Text] [Related]
10. Effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice. Chen T, Zhong FJ, Hong YM, Su WJ, Zhuang LL, Qiu LX. Chin J Nat Med; 2014 Mar; 12(3):194-8. PubMed ID: 24702805 [Abstract] [Full Text] [Related]
11. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis. Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC. J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649 [Abstract] [Full Text] [Related]
12. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice. Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, Park KG, Lee IK. Life Sci; 2012 Jan 30; 90(5-6):200-5. PubMed ID: 22154902 [Abstract] [Full Text] [Related]
13. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis. dela Peña A, Leclercq IA, Williams J, Farrell GC. J Hepatol; 2007 Feb 30; 46(2):304-13. PubMed ID: 17157947 [Abstract] [Full Text] [Related]
14. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Tomita K, Tamiya G, Ando S, Ohsumi K, Chiyo T, Mizutani A, Kitamura N, Toda K, Kaneko T, Horie Y, Han JY, Kato S, Shimoda M, Oike Y, Tomizawa M, Makino S, Ohkura T, Saito H, Kumagai N, Nagata H, Ishii H, Hibi T. Gut; 2006 Mar 30; 55(3):415-24. PubMed ID: 16174657 [Abstract] [Full Text] [Related]
15. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis. Yamazaki Y, Kakizaki S, Horiguchi N, Sohara N, Sato K, Takagi H, Mori M, Negishi M. Gut; 2007 Apr 30; 56(4):565-74. PubMed ID: 16950832 [Abstract] [Full Text] [Related]
17. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T, Mizutani A, Yokoyama H, Irie R, Sumimoto H, Takayanagi A, Miyashita K, Akao M, Tabata M, Tamiya G, Ohkura T, Hibi T. Hepatology; 2008 Aug 30; 48(2):458-73. PubMed ID: 18666257 [Abstract] [Full Text] [Related]
18. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis. Sugino H, Kumagai N, Watanabe S, Toda K, Takeuchi O, Tsunematsu S, Morinaga S, Tsuchimoto K. J Gastroenterol Hepatol; 2008 Dec 30; 23(12):1909-16. PubMed ID: 18422963 [Abstract] [Full Text] [Related]
19. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. Ding Y, Sun X, Chen Y, Deng Y, Qian K. Eur J Pharmacol; 2015 Aug 15; 761():405-12. PubMed ID: 25967348 [Abstract] [Full Text] [Related]
20. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice. Kubota N, Kado S, Kano M, Masuoka N, Nagata Y, Kobayashi T, Miyazaki K, Ishikawa F. Clin Exp Pharmacol Physiol; 2013 Jul 15; 40(7):422-30. PubMed ID: 23611112 [Abstract] [Full Text] [Related] Page: [Next] [New Search]